Professor Kittiyod Poovorawan
Contact information
Research groups
Kittiyod Poovorawan
Associate Professor and Research Physician
An Associate Professor in the Department of Clinical Tropical Medicine, Faculty of Tropical Medicine (FTM) at Mahidol University in Bangkok, Kittiyod Poovorawan has been a member of MORU’s Clinical Therapeutics Unit (CTU) since 2019.
A Thai medical doctor board-certified in internal medicine and gastroenterology, Kittiyod has expertise in internal medicine, gastroenterology, hepatology, and clinical research of tropical diseases.
Kittiyod specialises in both teaching and clinical research. He teaches students from the Diploma, MSc, and PhD courses at the Bangkok School of Tropical Medicine, works as a gastroenterology consultant physician, and is the deputy director of the Hospital for Tropical Diseases in Bangkok.
Kittiyod’s primary research area is liver diseases including viral hepatitis, liver abscess, chronic liver disease, and gastrointestinal involvement in tropical diseases. He is experienced in conducting clinical trials on viral hepatitis and tropical infectious diseases. He is a part of an active clinical research team, conducting several research projects including pharmacological studies of antimalarial, platform studies in COVID-19, and The Malaria Infection Study in Thailand (MIST).
Kittiyod has published more than 60 international peer-reviewed research articles and his current and future research focusses on tropical infectious diseases and viral hepatitis elimination.
Recent publications
-
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Journal article
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
-
A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults.
Journal article
Hanboonkunupakarn B. et al, (2024), NPJ vaccines, 9
-
Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update.
Journal article
Cooke GS. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 346 - 365
-
Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
Journal article
Pukrittayakamee S. et al, (2024), eLife, 12
-
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Preprint
Wongnak P. et al, (2024)